Clinical trial
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study
NCT02619760 is registered in ClinicalTrials.gov with Kyoto University, Graduate School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study
- Lead sponsor
- Kyoto University, Graduate School of Medicine
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- December 31, 2023
- Enrollment
- 3,045 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.